Key Laboratory of Life-organic Analysis of Shandong Province & Key Laboratory of Pharmaceutical Intermediates and Natural Medicine Analysis, College of Chemistry and Chemical Engineering, Qufu Normal University, Qufu, 273165, Shandong, People's Republic of China.
Qinghai Key Laboratory of Qinghai-Tibet Plateau Biological Resources, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining, 810001, Qinghai, People's Republic of China.
Mikrochim Acta. 2020 Jun 5;187(7):373. doi: 10.1007/s00604-020-04341-4.
A new series of 9-plex chemical isotope-labeling reagents, levofloxacin-based mass tags (LMTs) named as LMT359, 360, 361, 362, 363, 373, 375, 376, and 378, was firstly designed and synthesized for the high-throughput labeling of globotriaosylsphingosine (lyso-Gb3), a disease biomarker of Fabry disease. Creatively based on derivatization strategy-dummy template technique, dummy magnetic molecularly imprinted polymers (DMMIPs) were designed and prepared using LMT387-labeled lyso-Gb3 as a dummy template. The novel DMMIP material was used as sorbents for magnetic dispersive solid-phase extraction of 9-plexed LMT derivatives of lyso-Gb3 from equally mixed derivatization solutions. The enriched 8-plexed lyso-Gb3 derivatives from 8 real samples were quantified by ultra-high-performance liquid chromatography tandem mass spectrometry in a single run using simultaneously extracted LMT359-labeled standard lyso-Gb3 as internal standards. DMMIPs were characterized by using the transmission electron microscope (TEM), Fourier transform infrared, X-ray photoelectron spectroscopy, and some other characterization techniques. TEM micrograph showed that the prepared DMMIPs had an apparent imprinting layer. Triple-recognition abilities of DMMIPs towards LMT-lyso-Gb3 mainly rely on the hydrogen bonding, electrostatic attraction, hydrophobic interaction, and boronate affinity. The imprinting factor of DMMIPs towards LMT-lyso-Gb3 was 5.1. This method shows the advantages of high selectivity (triple recognition), high sensitivity, high accuracy (recovery 93.5-108.8%), and high throughput (8 samples in a single run). The proposed method was successfully applied to the determination of lyso-Gb3 in plasma samples with spiked recoveries in the range of 95.0-102.4%. This indicates that the method is promising in bioanalysis and medical testing of lyso-Gb3 in the future. Graphical abstract Synthesis of multiplexed derivatization reagents and its correlative molecularly imprinted polymers for magnetic extraction of globotriaosylsphingosine.
一种新的 9 重化学同位素标记试剂系列,基于左氧氟沙星的质量标签(LMT),命名为 LMT359、360、361、362、363、373、375、376 和 378,首次被设计和合成,用于高通量标记神经酰胺三己糖苷(lyso-Gb3),这是法布里病的疾病生物标志物。创造性地基于衍生化策略-虚拟模板技术,使用 LMT387 标记的 lyso-Gb3 作为虚拟模板,设计并制备了虚拟磁性分子印迹聚合物(DMMIP)。新型 DMMIP 材料被用作从等量混合衍生化溶液中磁性分散固相萃取 9 重 lyso-Gb3 的 LMT 衍生物的吸附剂。从 8 个实际样品中富集的 8 重 lyso-Gb3 衍生物在单次运行中通过超高效液相色谱串联质谱法进行定量分析,同时提取 LMT359 标记的标准 lyso-Gb3 作为内标。通过透射电子显微镜(TEM)、傅里叶变换红外光谱、X 射线光电子能谱等一些其他表征技术对 DMMIP 进行了表征。TEM 照片显示,制备的 DMMIP 具有明显的印迹层。DMMIP 对 LMT-lyso-Gb3 的三重识别能力主要依赖于氢键、静电吸引、疏水相互作用和硼酸亲和性。DMMIP 对 LMT-lyso-Gb3 的印迹因子为 5.1。该方法具有高选择性(三重识别)、高灵敏度、高准确性(回收率 93.5-108.8%)和高通量(单次运行 8 个样品)的优点。该方法成功应用于血浆样品中 lyso-Gb3 的测定,加标回收率在 95.0-102.4%范围内。这表明该方法在未来 lyso-Gb3 的生物分析和医学检测中具有广阔的应用前景。